Company / Cost of Revenue
STAAR Surgical Company Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$57.0M
FY2025
5-year range
$38.2M / $74.3M
FY2021-FY2025
Trend
-23.3%
vs FY2024
Sector context
#101 of 113
Health Care
What the data says
STAAR Surgical Company's cost of revenue of $57M is lower than 89% of companies in the Health Care sector (FY2025). Cost of Revenue has fluctuated over the past 10 years, ranging from $24M in FY2018 to $74M in FY2024.
Based on SEC 10-K filings.
$57M in FY2025 with a 5-year CAGR of +11.9%.
Improved from $70M to $57M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -2.2%
- 5-Year CAGR
- +11.9%
- 10-Year CAGR
- -
Sector benchmark
Top 11% in Health CareTop 11% of 113This company $57.0M Sector average $11.3B
▼
-99.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +11.9%, indicating consistent growth.
- In FY2025, cost of revenue decreased 23.3% year-over-year.
- Ranks #101 out of 113 companies in the Health Care sector.
- Peak cost of revenue was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Negative profit margin: -6.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $57.0M | -23.3% |
| FY2024 | $74.3M | +6.5% |
| FY2023 | $69.8M | +14.4% |
| FY2022 | $61.0M | +59.6% |
| FY2021 | $38.2M | +17.8% |
| FY2020 | $32.4M | -15.1% |
| FY2019 | $38.2M | +58.9% |
| FY2018 | $24.1M | -1.4% |
| FY2017 | $24.4M | +1.4% |
| FY2016 | $24.1M | -1.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026